atrial fibrillation

Latest Headlines

Latest Headlines

Medtronic debuts European study of its atrial fibrillation device

Medtronic said it has begun enrollment in a European clinical trial of its atrial fibrillation device as part of its efforts to eventually gain FDA approval for its Phased RF technology, which would be a first-of-its-kind system.

American College of Cardiology meeting supportive of ablation to treat warning sign of stroke

In a win for cardiac ablation device makers like Johnson & Johnson's Biosense Webster and AtriCure, two studies presented at the American College of Cardiology's annual meeting in San Diego concluded that performing atrial fibrillation ablation improves outcomes.

Study: Tiny, insertable Medtronic cardiac monitor found more effective in AF detection

The latest clinical trial results for Medtronic's insertable cardiac monitor show that it's effective at detecting atrial fibrillation at an even higher rate than found in a previous study. That could help the company make its case for reimbursement for the smallest cardiac monitor available, the Reveal Linq, which was launched early last year.

St. Jude gains FlexAbility approval, lays out 2015 sales growth strategy

St. Jude Medical has won FDA approval for its FlexAbility Ablation Catheter. This is the first irrigated ablation catheter with a flexible tip to be available in the U.S. The technology is used by electrophysiologists in the treatment of cardiac arrhythmias.

AliveCor aims for widespread consumer adoption with new tech, reduced price

AliveCor has reduced the price on its ECG monitor to $74.99 from $199; it's also now a third-generation device that is 50% thinner and 40% lighter.

iRhythm wearable cardiac monitor gets CE mark, CardioLogic partners to sell it in U.K.

iRhythm has received a CE mark in Europe for its continuous heart monitoring Zio Service. The technology enables up to 14 days of continuous heart monitoring via a wireless patch; it includes analytical software, as well as report to the physician. In addition, iRhythm has partnered with cardiology distributor CardioLogic to market Zio in the U.K. for the diagnosis of atrial fibrillation and other cardiac arrhythmias.

Boston Scientific backs atrial fibrillation startup Iowa Approach

Boston Scientific has invested in Iowa Approach, a new startup devoted to its novel atrial fibrillation (AF) ablation technology. The technique is expected to be easier and cheaper than the current AF ablation procedures; there are about 400,000 ablations to treat AF annually. The company expects to be ready for testing in humans in 2016.

Boehringer taps WellPoint's outcomes data to develop new a-fib drugs

Boehringer Ingelheim is working with managed care giant WellPoint in an effort to use real-world data to inform the development of new treatments of atrial fibrillation, keeping up with a sweeping trend in cardiovascular R&D.

AliveCor heart monitor, app added to GreatCall's health-focused smartphone

GreatCall, maker of mobile health and safety apps, is adding the AliveCor Heart Monitor for detecting atrial fibrillation to its offerings. Alivecor's electrocardiogram can now be mounted to back of the GreatCall3 smartphone and used with the AliveECG app.

Swedes, Harvard and more find success with DNA test for Afib risks

Researchers in Sweden and colleagues in Europe and the U.S. say they've found success with a blood test that screens for 12 biomarkers pointing to an increased likelihood of atrial fibrillation, an abnormal heart rhythm that can cause all kinds of cardiac health risks.